Biomedicines, Free Full-Text
Lipid-Based Poly(I:C) Adjuvants Strongly Enhance the Immunogenicity of SARS-CoV-2 Receptor-Binding Domain Vaccine
News & Comment Cellular & Molecular Immunology
PDF) New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein
Current advances in the development of SARS-CoV-2 vaccines
Frontiers Immunity to SARS-CoV-2: Lessons Learned
News & Comment Cellular & Molecular Immunology
Browse Articles Cellular & Molecular Immunology
Comprehensive characterization of the antibody responses to SARS
The SARS-CoV-2 spike protein is vulnerable to moderate electric fields
Novel vaccine strategy protects mice from COVID-19 and 4 related coronaviruses
PDF) Modern Paradigm Towards Potential Target Identification for Antiviral (SARS-nCoV-2) and Anticancer Lipopeptides: A Pharmacophore-Based Approach
